Comment on Medicine Access Programmes: what do patients think – a patient‐reported outcome study on ribociclib in metastatic breast cancer in Australia

Documenti analoghi

• Medicine Access Programmes: what do patients think – a patient‐reported outcome study on ribociclib in metastatic breast cancer in Australia
  di: Natasha Yap, et al.
  Pubblicazione: (2024)
• Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in Australia
  di: Lynette Chee, et al.
  Pubblicazione: (2024)
• Evaluation of early fluoropyrimidine toxicity in solid organ cancer patients: a retrospective observational study in Australia
  di: Cassandra White, et al.
  Pubblicazione: (2024)
• Examining capillary ketone testing in hospitalised patients: indications and outcomes
  di: Thomas Kent, et al.
  Pubblicazione: (2024)
• Fatigue and mood disorders are highly prevalent in patients with inflammatory bowel disease: A single‐centre, cross‐sectional study using patient‐reported outcomes
  di: Andrew Chen, et al.
  Pubblicazione: (2026)